Washington Fertility Center – FDA 483, Nov 2, 2023
The FDA inspected Washington Fertility Center, a reproductive human tissue establishment in Annandale, VA, and found significant, often repeated, deficiencies. The firm failed to properly determine and document donor eligibility, inadequately screened and tested donors for communicable diseases like Zika, WNV, HIV, and HBV, and lacked appropriate written procedures for these critical processes. Additionally, documentation of eligibility determinations was flawed, and HCT/Ps not requiring full eligibility were improperly labeled.
- Person
ID · f6f8e43e-a3cf-436e-84e2-1e61f7c4da0b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.